Requests for Nominations of Candidates and Suggested Meeting Topics for the Clinical Laboratory Improvement Advisory Committee (CLIAC), 45506 [2016-16580]
Download as PDF
<![CDATA[
45506
Federal Register / Vol. 81, No. 135 / Thursday, July 14, 2016 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
asabaliauskas on DSK3SPTVN1PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Requests for Nominations of
Candidates and Suggested Meeting
Topics for the Clinical Laboratory
Improvement Advisory Committee
(CLIAC)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
Funding Opportunity Announcement
(FOA) GH16–007, Operations Research
(Implementation Science) for
Strengthening Global Health Protection
Implementation.
Times and Dates: 9:00 a.m.–2:00 p.m.,
EDT, Panel A, August 8, 2016 (Closed);
9:00 a.m.–2:00 p.m., EDT, Panel B,
August 9, 2016 (Closed); 9:00 a.m.–2:00
p.m., EDT, Panel C, August 10, 2016
(Closed).
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in section 552b(c)(4)
and (6), title 5 U.S.C., and the
Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters for Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
FOA GH–007 Operations Research
(Implementation Science) for
Strengthening Global Health Protection
Implementation.
Contact Person for More Information:
Hylan Shoob, Scientific Review Officer,
Center for Global Health (CGH) Science
Office, CGH, CDC, 1600 Clifton Road
NE., Mailstop D–69, Atlanta, Georgia
30033, Telephone: (404) 639–4796.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2016–16582 Filed 7–13–16; 8:45 am]
BILLING CODE 4163–18–P
VerDate Sep<11>2014
19:33 Jul 13, 2016
Jkt 238001
Correction: This notice was published
in the Federal Register on June 7, 2016,
81 FR 36543. The Request for
Candidates should read as follows:
Request For Candidates: Nominations
are being sought for individuals who
have expertise and qualifications
necessary to contribute to
accomplishing CLIAC’s objectives.
Nominees will be selected by the HHS
Secretary or designee from authorities
knowledgeable across the fields of
microbiology (including bacteriology,
mycobacteriology, mycology,
parasitology, and virology), immunology
(including histocompatibility),
chemistry, hematology, pathology
(including histopathology and cytology),
or genetic testing (including
cytogenetics); representatives from the
fields of medical technology, public
health, and clinical practice; and
consumer representatives. Members
may be invited to serve for terms of up
to four years.
The U.S. Department of Health and
Human Services policy stipulates that
Committee membership be balanced in
terms of points of view represented, and
the committee’s function. Appointments
shall be made without discrimination
on the basis of age, race, ethnicity,
gender, sexual orientation, gender
identity, HIV status, disability, and
cultural, religious, or socioeconomic
status. Nominees must be U.S. citizens,
and cannot be full-time employees of
the U.S. Government. Current
participation on federal workgroups or
prior experience serving on a federal
advisory committee does not disqualify
a candidate; however, HHS policy is to
avoid excessive individual service on
advisory committees and multiple
committee memberships. Committee
members are Special Government
Employees, requiring the filing of
financial disclosure reports at the
beginning and annually during their
terms. CDC reviews potential candidates
for CLIAC membership each year, and
provides a slate of nominees for
consideration to the Secretary of HHS
for final selection. HHS notifies selected
candidates of their appointment near
the start of the term in July, or as soon
as the HHS selection process is
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
completed. Note that the need for
different expertise varies from year to
year and a candidate who is not selected
in one year may be reconsidered in a
subsequent year.
Candidates should submit the
following items to be considered for
nomination. The deadline for receipt of
materials for the 2017 term is August 1,
2016:
• Current curriculum vitae, including
complete contact information (name,
affiliation, mailing address, telephone
number, email address).
• Letter(s) of recommendation from
person(s) not employed by the U.S.
Department of Health and Human
Services.
FOR FURTHER INFORMATION CONTACT:
Nancy Anderson, Chief, Laboratory
Practice Standards Branch, Division of
Laboratory Systems, Center for
Surveillance, Epidemiology and
Laboratory Services, Office of Public
Health Scientific Services, Centers for
Disease Control and Prevention, 1600
Clifton Road NE., Mailstop F–11,
Atlanta, Georgia 30329–4018; telephone
(404) 498–2741; or via email at
NAnderson@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both the
Centers for Disease Control and
Prevention, and the Agency for Toxic
Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2016–16580 Filed 7–13–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with sction 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
Funding Opportunity Announcement
(FOA) CK17–1701, Emerging Infections
Programs.
Time and Date: 10:00 a.m.–5:00 p.m., EDT,
August 30–31, 2016 (Closed).
E:\FR\FM\14JYN1.SGM
14JYN1
]]>Agencies
[Federal Register Volume 81, Number 135 (Thursday, July 14, 2016)]
[Notices]
[Page 45506]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-16580]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Requests for Nominations of Candidates and Suggested Meeting
Topics for the Clinical Laboratory Improvement Advisory Committee
(CLIAC)
Correction: This notice was published in the Federal Register on
June 7, 2016, 81 FR 36543. The Request for Candidates should read as
follows:
Request For Candidates: Nominations are being sought for
individuals who have expertise and qualifications necessary to
contribute to accomplishing CLIAC's objectives. Nominees will be
selected by the HHS Secretary or designee from authorities
knowledgeable across the fields of microbiology (including
bacteriology, mycobacteriology, mycology, parasitology, and virology),
immunology (including histocompatibility), chemistry, hematology,
pathology (including histopathology and cytology), or genetic testing
(including cytogenetics); representatives from the fields of medical
technology, public health, and clinical practice; and consumer
representatives. Members may be invited to serve for terms of up to
four years.
The U.S. Department of Health and Human Services policy stipulates
that Committee membership be balanced in terms of points of view
represented, and the committee's function. Appointments shall be made
without discrimination on the basis of age, race, ethnicity, gender,
sexual orientation, gender identity, HIV status, disability, and
cultural, religious, or socioeconomic status. Nominees must be U.S.
citizens, and cannot be full-time employees of the U.S. Government.
Current participation on federal workgroups or prior experience serving
on a federal advisory committee does not disqualify a candidate;
however, HHS policy is to avoid excessive individual service on
advisory committees and multiple committee memberships. Committee
members are Special Government Employees, requiring the filing of
financial disclosure reports at the beginning and annually during their
terms. CDC reviews potential candidates for CLIAC membership each year,
and provides a slate of nominees for consideration to the Secretary of
HHS for final selection. HHS notifies selected candidates of their
appointment near the start of the term in July, or as soon as the HHS
selection process is completed. Note that the need for different
expertise varies from year to year and a candidate who is not selected
in one year may be reconsidered in a subsequent year.
Candidates should submit the following items to be considered for
nomination. The deadline for receipt of materials for the 2017 term is
August 1, 2016:
Current curriculum vitae, including complete contact
information (name, affiliation, mailing address, telephone number,
email address).
Letter(s) of recommendation from person(s) not employed by
the U.S. Department of Health and Human Services.
FOR FURTHER INFORMATION CONTACT: Nancy Anderson, Chief, Laboratory
Practice Standards Branch, Division of Laboratory Systems, Center for
Surveillance, Epidemiology and Laboratory Services, Office of Public
Health Scientific Services, Centers for Disease Control and Prevention,
1600 Clifton Road NE., Mailstop F-11, Atlanta, Georgia 30329-4018;
telephone (404) 498-2741; or via email at NAnderson@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities for
both the Centers for Disease Control and Prevention, and the Agency for
Toxic Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2016-16580 Filed 7-13-16; 8:45 am]
BILLING CODE 4163-18-P
